IL134371A0 - Composition and method for regulating cell proliferation and cell death - Google Patents

Composition and method for regulating cell proliferation and cell death

Info

Publication number
IL134371A0
IL134371A0 IL13437198A IL13437198A IL134371A0 IL 134371 A0 IL134371 A0 IL 134371A0 IL 13437198 A IL13437198 A IL 13437198A IL 13437198 A IL13437198 A IL 13437198A IL 134371 A0 IL134371 A0 IL 134371A0
Authority
IL
Israel
Prior art keywords
composition
cell
regulating
dna
cell proliferation
Prior art date
Application number
IL13437198A
Other languages
English (en)
Original Assignee
Bioniche Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioniche Life Sciences Inc filed Critical Bioniche Life Sciences Inc
Publication of IL134371A0 publication Critical patent/IL134371A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL13437198A 1997-08-05 1998-08-05 Composition and method for regulating cell proliferation and cell death IL134371A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5477797P 1997-08-05 1997-08-05
US7506798P 1998-02-18 1998-02-18
US7511198P 1998-02-18 1998-02-18
US8631798P 1998-05-21 1998-05-21
PCT/CA1998/000744 WO1999007383A1 (en) 1997-08-05 1998-08-05 Composition and method for regulating cell proliferation and cell death

Publications (1)

Publication Number Publication Date
IL134371A0 true IL134371A0 (en) 2001-04-30

Family

ID=27489673

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13437198A IL134371A0 (en) 1997-08-05 1998-08-05 Composition and method for regulating cell proliferation and cell death
IL134371A IL134371A (en) 1997-08-05 2000-02-03 Preparation and method for controlling cell proliferation and cell death
IL180924A IL180924A (en) 1997-08-05 2007-01-24 Method for regulating cell proliferation and cell death

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL134371A IL134371A (en) 1997-08-05 2000-02-03 Preparation and method for controlling cell proliferation and cell death
IL180924A IL180924A (en) 1997-08-05 2007-01-24 Method for regulating cell proliferation and cell death

Country Status (17)

Country Link
US (2) US6329347B1 (de)
EP (1) EP1003525B1 (de)
JP (2) JP4335435B2 (de)
KR (1) KR100533576B1 (de)
AT (1) ATE227996T1 (de)
AU (1) AU736450B2 (de)
BR (1) BR9815602A (de)
CA (1) CA2299548C (de)
DE (1) DE69809561T2 (de)
DK (1) DK1003525T3 (de)
ES (1) ES2187047T3 (de)
HU (1) HU227921B1 (de)
IL (3) IL134371A0 (de)
NO (1) NO322450B1 (de)
NZ (1) NZ502674A (de)
PT (1) PT1003525E (de)
WO (1) WO1999007383A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4335435B2 (ja) 1997-08-05 2009-09-30 バイオニケ ライフ サイエンシーズ インコーポレイテッド 細胞増殖および細胞死を調節する組成物および方法
DE69829316T2 (de) * 1998-02-18 2006-04-13 Bioniche Life Sciences Inc., Belleville Behandlung des harnblasenkrebses durch mycobacterium phlei zellwand
US6809081B1 (en) * 1998-12-04 2004-10-26 Bioniche Life Sciences, Inc. Chemotherapeutic composition and method
WO2000033875A1 (en) * 1998-12-04 2000-06-15 Bioniche Life Sciences Inc. Chemotherapeutic composition and method
ATE273027T1 (de) * 1998-12-04 2004-08-15 Bioniche Life Sciences Inc Zusammensetzung zur behandlung von entzündungen
JP2002541114A (ja) * 1999-04-01 2002-12-03 バイオニケ ライフ サイエンシーズ インコーポレイテッド 前立腺癌の細胞におけるアポプトーシス誘導のための組成物および方法
US6794368B1 (en) 1999-04-01 2004-09-21 Bioniche Life Sciences Inc. Composition and method for inducing apoptosis in prostate cancer cells
US7314926B1 (en) 1999-04-08 2008-01-01 Antisoma Research Limited Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin
AU7501700A (en) * 1999-09-29 2001-04-30 Bioniche Life Sciences Inc. Method to disrupt mitochondrial function
PT1238070E (pt) * 1999-12-13 2007-11-06 Bioniche Life Sciences Inc Oligonucleótidos sintéticos úteis sob o ponto de vista terapêutico
EP1250152B1 (de) * 1999-12-28 2013-05-15 Bioniche Urology IP Inc. Hyaluronsäure enthaltende synergistische Zusammensetzung zur Krebsbehandlung
US20030044352A1 (en) * 2001-04-24 2003-03-06 Phillips Nigel C. Method for evaluating the efficacy of treatment with bacterial DNA and bacterial cell walls
US6673566B1 (en) 2002-01-10 2004-01-06 The United States Of America As Represented By The Secretary Of Agriculture Diagnosis of pathogen infections through analysis of nitrite production by antigen stimulated leukocytes
EP2043692B1 (de) * 2006-07-25 2016-05-18 Lipoxen Technologies Limited Polysaccharidderivate des erythropoietin
AU2011315093B2 (en) 2010-10-13 2013-10-17 Telesta Therapeutics Ip Inc. Bacterial ribonucleic acid cell wall compositions and methods of making and using them

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
FR2160326B1 (de) 1971-11-19 1975-02-07 Anvar
US4152423A (en) 1971-11-19 1979-05-01 Agence Nationale De Valorisation De La Recherche (Anvar) Immunological agents
CH602920A5 (de) 1973-02-23 1978-08-15 Wellcome Found
US3976544A (en) 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
FR2374042A1 (fr) 1976-06-04 1978-07-13 Merieux Inst Nouveau medicament immunostimulant et son procede de preparation
JPS54140710A (en) 1978-03-10 1979-11-01 Mitsui Toatsu Chem Inc Anti-tumor substance and its preparation
DE3011461C2 (de) 1980-03-25 1986-10-30 Dr. Madaus & Co, 5000 Köln Verwendung von Propionibakterien
US4520019A (en) 1982-04-29 1985-05-28 Ribi Immunochem Research, Inc. Stable composition and preparation thereof
US4579941A (en) 1982-08-13 1986-04-01 Mitsuitoatsu Chemicals, Inc. Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent
US4663306A (en) 1983-09-23 1987-05-05 Ribi Immunochem Research, Inc. Pyridine-soluble extract-refined detoxified endotoxin composition and use
GB8404280D0 (en) 1984-02-17 1984-03-21 Stanford J L Biological preparations
US4744984A (en) 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
US4877611A (en) 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
AU691797B2 (en) 1993-01-29 1998-05-28 Vetrepharm, Inc. Immunotherapeutic composition
JP4335435B2 (ja) 1997-08-05 2009-09-30 バイオニケ ライフ サイエンシーズ インコーポレイテッド 細胞増殖および細胞死を調節する組成物および方法

Also Published As

Publication number Publication date
JP4335435B2 (ja) 2009-09-30
NO20000576D0 (no) 2000-02-04
JP2008208140A (ja) 2008-09-11
NO20000576L (no) 2000-04-04
AU736450B2 (en) 2001-07-26
IL180924A0 (en) 2007-07-04
NO322450B1 (no) 2006-10-09
HUP0003012A3 (en) 2004-03-29
IL134371A (en) 2007-07-24
EP1003525B1 (de) 2002-11-20
IL180924A (en) 2010-11-30
DK1003525T3 (da) 2003-03-24
WO1999007383A1 (en) 1999-02-18
DE69809561T2 (de) 2003-09-25
US6326357B1 (en) 2001-12-04
CA2299548C (en) 2009-12-29
HUP0003012A2 (hu) 2000-12-28
US6329347B1 (en) 2001-12-11
KR20010022643A (ko) 2001-03-26
EP1003525A1 (de) 2000-05-31
ES2187047T3 (es) 2003-05-16
DE69809561D1 (de) 2003-01-02
HU227921B1 (hu) 2012-06-28
WO1999007383B1 (en) 1999-03-25
CA2299548A1 (en) 1999-02-18
BR9815602A (pt) 2001-12-11
NZ502674A (en) 2002-06-28
AU8723698A (en) 1999-03-01
PT1003525E (pt) 2003-03-31
KR100533576B1 (ko) 2005-12-05
ATE227996T1 (de) 2002-12-15
JP2001513504A (ja) 2001-09-04

Similar Documents

Publication Publication Date Title
IL180924A0 (en) Method for regulating cell proliferation and cell death
ATE260989T1 (de) Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen
IL148152A0 (en) Sequence-specific dna recombination in eukaryotic cells
IL127964A0 (en) A method for determining the efficacy of active agents
GB9215834D0 (en) Cell culture
CA2171618A1 (en) Purine nucleoside phosphorylase gene therapy for human malignancy
EP1674565A3 (de) Verfahren zur Erhöhung der Enzym-Aktivität bei erhöhter Temperatur
ZA971158B (en) Nucleic acid constructs for the cell cycle-regulated expression of genes, cells containing such constructs and their use for preparing drugs.
DE3573135D1 (en) Method for purifying reaction solution obtained by using microbial cell, immobilized microbial cell, or immobilized enzyme
ES8403157A1 (es) Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral.
FI885436A7 (fi) Fermenttori soluviljelmien viljelemiseksi
AU1686288A (en) Amperometric method for the quantitative determination of 1,4-dihydronicotinamide adenine dinucleotide (nadh) in solution
DE3875396D1 (de) Mikrotraegermaterial fuer die zellkultur.
AU1820388A (en) Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
AU5168099A (en) Use of novel agents inducing cell death in synergy with interferons
FI801752A7 (fi) Menetelmä mikro-organismien aineenvaihdunta-aktiviteetin optimoimiseksi biologisen reaktiojärjestereaktiojärjestelmän substraatissa.
ATE273027T1 (de) Zusammensetzung zur behandlung von entzündungen
RU96120030A (ru) Противолучевое средство
JPS52156991A (en) Method for increasing activity of immobilized enzymes
BG103733A (en) Isolated genes and proteins encoding resistance to photosensibilizers
EP1165106B8 (de) Zusammensetzung und methode zur induzierung von apoptosis in prostatakrebszellen mittels m-dna und mcc
ITUD950066A0 (it) Procedimento per la preparazione e la conservazione di colture cellulari, o di parti di cellule, allo stato pronto per dosaggi biologici
JPS5399385A (en) Method for preparing immobilized enzyme bonded to cell membrance
RU2000106057A (ru) Применение никотинамидадениндинуклеотида и его аналогов для лечения злокачественных и инфекционных заболеваний
FI862503A7 (fi) Tuki ihmisten ja/tai eläinten solujen viljelemiseksi fermentointilaitteessa.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed